Allena Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch ALNAQ and buy or sell other stocks, ETFs, and their options commission-free!

About ALNAQ

Allena Pharmaceuticals, Inc. engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease.

CEO

Louis Brenner, MD, MBA

CEOLouis Brenner, MD, MBA

Employees

—

Employees—

Headquarters

Sudbury, Massachusetts

HeadquartersSudbury, Massachusetts

Founded

2011

Founded2011

Employees

—

Employees—

ALNAQ Key Statistics

Market cap

100.00

Market cap100.00

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

19.55K

Average volume19.55K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.0185

52 Week high$0.0185

52 Week low

—

52 Week low—

People also own

Based on the portfolios of people who own ALNAQ. This list is generated using Robinhood data, and it’s not a recommendation.

Zomedica

SNDL

Tonix Pharmaceuticals

Exela Technologies

Cenntro Electric Group Li…

Camber Energy